Summary
Samenvatting MTB 1 (inclusief hoorcolleges)
Book
Leerboek epidemiologie
Samenvatting van Methodologie en Biostatistiek 1. De samenvatting bevat alle relevante informatie uit Bouter et al., Twisk, hoorcolleges en lesstof van de werkcolleges.
[Show more]
Preview 4 out of 150 pages
Summarized whole book?
No
Which chapters are summarized?
H1, h2, h3, h4, h5, h6, h8, h9, h10
Uploaded on
October 26, 2019
Number of pages
150
Written in
2019/2020
Type
Summary
Book Title: Leerboek epidemiologie
Author(s): L.M. Bouter, M.C.J.M. van Dongen
Edition: januari 2016
ISBN: 9789036805612
Edition: 7
Institution
Vrije Universiteit Amsterdam (VU)
Education
Health Sciences
Course
Methodologie en biostatistiek I (AP_470901)
All documents for this subject (1)
By: floortjewesthof • 1 week ago
$7.55
Added
Add to cart
Add to wishlist
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
2019
Samenvatting MTB
BLOK 1
LOES KIEVITSBOSCH
, Epidemiologie 1
CONTENTS
Epidemiologie.......................................................................................................................................................... 4
Frequentiematen ................................................................................................................................................ 5
Plotselinge uitbraken .............................................................................................................................................. 9
Attack rate ........................................................................................................................................................... 9
Reproductiegetal ................................................................................................................................................. 9
Epidemische curve ............................................................................................................................................ 11
Onderzoeksopzet .................................................................................................................................................. 13
Onderzoeksdesigns ........................................................................................................................................... 14
Cohortonderzoek .......................................................................................................................................... 15
Patiënt-controleonderzoek ........................................................................................................................... 16
Cross-sectioneel onderzoek .............................................................................................................................. 18
Ecologisch onderzoek ........................................................................................................................................ 18
Proces randomized onderzoek .......................................................................................................................... 19
Frequentie ............................................................................................................................................................. 20
Associatiematen .................................................................................................................................................... 24
Betrouwbaarheid en validiteit .............................................................................................................................. 27
Betrouwbaarheid .............................................................................................................................................. 27
Reproduceerbaarheid ................................................................................................................................... 27
Validiteit ............................................................................................................................................................ 27
Interne validiteit ............................................................................................................................................ 27
Externe validiteit ........................................................................................................................................... 28
Toevallige fouten........................................................................................................................................... 29
Systematische fouten .................................................................................................................................... 29
Gouden standaard......................................................................................................................................... 29
Bias .................................................................................................................................................................... 30
Selectiebias ................................................................................................................................................... 30
Selectieve uitval ............................................................................................................................................ 32
Informatiebias ............................................................................................................................................... 32
Confounding .................................................................................................................................................. 33
Effectmodificatie ........................................................................................................................................... 34
Vertekening verhelpen ...................................................................................................................................... 34
Randomisatie ................................................................................................................................................ 35
Restrictie ....................................................................................................................................................... 35
Matchen ........................................................................................................................................................ 35
Standaardfout ............................................................................................................................................... 36
1
, Epidemiologie 2
Stratificatie .................................................................................................................................................... 37
Standaardisatie ............................................................................................................................................. 37
Schematische weergave confounding/effectmodificatie ................................................................................. 37
Multivariabele regressieanalyse ................................................................................................................... 37
Causale diagrammen ..................................................................................................................................... 38
Betrouwbaarheidsinterval ................................................................................................................................ 39
Etiologie en causaliteit .......................................................................................................................................... 41
Levels of evidence ............................................................................................................................................. 42
Preventie ........................................................................................................................................................... 42
Diagnostiek en prognostiek................................................................................................................................... 42
Soorten validiteit ............................................................................................................................................... 44
Maten ter kwantificatie van diagnostische tests .......................................................................................... 44
Likelihood ratio ................................................................................................................................................. 46
Likelihood ratio van een positieve testuitslag ............................................................................................... 46
Likelihood ratio van een negatieve testuitslag ............................................................................................. 46
Predictieve waarden ......................................................................................................................................... 47
Positieve predictieve waarde ........................................................................................................................ 47
Negatieve predictieve waarde ...................................................................................................................... 47
Testen combineren ........................................................................................................................................... 47
In serie geschakelde tests ............................................................................................................................. 47
Parallelle tests ............................................................................................................................................... 48
Inter- en intrabeoordelaarsovereenkomst ....................................................................................................... 48
Percentage overeenstemming ...................................................................................................................... 48
Cohen’s kappa ............................................................................................................................................... 48
Correlatiecoëfficiënt ..................................................................................................................................... 49
Verdeling van verschillen tussen beide metingen per individu .................................................................... 49
Intraklassecorrelatiecoëfficiënt voor overeenstemming .............................................................................. 49
Interventie............................................................................................................................................................. 50
Uitvoering interventieonderzoek ...................................................................................................................... 50
Vertroebeling van onderzoeksresultaten.......................................................................................................... 51
Stratificatie .................................................................................................................................................... 52
Designs .............................................................................................................................................................. 53
Bijwerkingen medicatie ..................................................................................................................................... 53
Hypothesen testen ................................................................................................................................................ 55
Type fouten ....................................................................................................................................................... 56
Type 2 fout .................................................................................................................................................... 56
Type 1 fout .................................................................................................................................................... 56
2
, Epidemiologie 3
Type 3 fout .................................................................................................................................................... 57
One-independant sample z-test........................................................................................................................ 57
Non-directional, tweezijdige toets .................................................................................................................... 57
Z-toets ........................................................................................................................................................... 58
Directional, eenzijdige toets ............................................................................................................................. 58
Lower-tail critical hypothesis test (H1:<) ...................................................................................................... 58
Effect size .......................................................................................................................................................... 58
Cohen’s d....................................................................................................................................................... 59
Power ................................................................................................................................................................ 59
T-toets ................................................................................................................................................................... 61
Geschatte standaardfout (SM) .......................................................................................................................... 61
Vrijheidsgraden (df) .......................................................................................................................................... 61
T-verdeling ........................................................................................................................................................ 61
Geschatte d → Effect size ................................................................................................................................. 62
Percentage variantie als gevolg van de behandeling (r²) → Effect size ............................................................ 62
Betrouwbaarheidsinterval (BI) .......................................................................................................................... 62
Onafhankelijke t-toets....................................................................................................................................... 63
Geschatte variantie (pooled variance s²P) ........................................................................................................ 64
Statistiek................................................................................................................................................................ 66
Samenvatting werkgroepopdrachten ............................................................................................................... 66
Standaardiseren waardes.............................................................................................................................. 66
Meetniveaus.................................................................................................................................................. 66
Binomiale kansverdeling ............................................................................................................................... 67
Normale kansverdeling ................................................................................................................................. 67
T-verdeling .................................................................................................................................................... 68
Kansberekening ................................................................................................................................................. 68
Rekenregels ................................................................................................................................................... 68
Confounding/effectmodificatie ..................................................................................................................... 70
Toevalsovereenkomst ................................................................................................................................... 71
Cohen’s kappa ............................................................................................................................................... 71
Bijlage 1: Hoorcollege 1......................................................................................................................................... 73
Bijlage 2: Hoorcollege 2......................................................................................................................................... 90
Bijlage 3: Hoorcollege 3......................................................................................................................................... 97
Bijlage 4: Hoorcollege 4....................................................................................................................................... 108
Bijlage 5: Hoorcollege 5....................................................................................................................................... 121
Bijlage 6: Hoorcollege 6....................................................................................................................................... 130
Bijlage 7: Hoorcollege 7....................................................................................................................................... 140
3